4th World Congress of Biopharm Industry Development (BID-2025)

IN_PERSON

Event Link

Ready to Wow at the Conference?

Your paper deserves more than just slides.

showcase your research with researchbunny pages

Turn it into a multilingual audio brief, smart chat, and a sleek summary, all in one ResearchBunny Page.

Let your work speak for itself, literally.

Click here view demo

4th World Congress of Biopharm Industry Development (BID-2025)

Sep 24, 2025 - Sep 26, 2025

China, Shanghai

CONFERENCE

Registration

To join or learn more about the event, please visit the organizer's website.

Event Details

Location: Fengxian, Shanghai
Dates: September 24-26, 2025
Theme: Bridging Global High-end Talents, Empowering Industrial Innovation

The field of biopharma is at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapy and novel treatment options, biopharma is evolving at an unprecedented pace, offering new therapeutic choices to patients worldwide.

Event Overview

The BID-2025 conference aims to be one of the most significant events in the global biopharma field in 2025. It provides an exceptional platform for exchange, collaboration, and shaping the future direction of the biopharmaceutical industry.

Activities

Keynote Speeches by leading experts
Scientific Forums and Panel Discussions
Exhibitions and Poster Presentations
Networking Opportunities
Site Visits

Specialized Forums

Frontier Research in Drug Discovery
Cutting-Edge Drug Discovery Technologies
Drug Discovery Chemistry Innovation
Novel Drug Delivery Technologies and Systems
Gene and Cell Therapy Innovation & Development
Next-Generation Protein and Peptide Drugs
Pharmaceutical Process Development & Manufacturing

Invitation

This conference is dedicated to fostering mutual support and intellectual exchange among scientists and industry leaders globally. We sincerely invite global talents to join us in Shanghai to contribute to revitalizing international cooperation and advancing the Chinese biomedicine industry to the forefront of global innovation.